Application Sponsors
ANDA 214677 | FRESENIUS KABI USA | |
Marketing Status
Application Products
001 | SOLUTION;INTRAVENOUS | 200MG/20ML (10MG/ML) | 0 | LACOSAMIDE | LACOSAMIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-05-03 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
FRESENIUS KABI USA
cder:Array
(
[0] => Array
(
[ApplNo] => 214677
[companyName] => FRESENIUS KABI USA
[docInserts] => ["",""]
[products] => [{"drugName":"LACOSAMIDE","activeIngredients":"LACOSAMIDE","strength":"200MG\/20ML (10MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"05\/03\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-05-03
)
)